Status:
UNKNOWN
AI-Augmented Skin Cancer Diagnosis in Teledermatoscopy
Lead Sponsor:
Karolinska University Hospital
Collaborating Sponsors:
Karolinska Institutet
Medical University of Vienna
Conditions:
Skin Cancer
Melanoma
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
In this study an artificial intelligence (AI) tool for skin cancer diagnosis is implemented in a teleldermatoscopy platform. The aim is to study the effects on clinician diagnostic accuracy, managemen...
Detailed Description
Deep-learning algorithms can potentially benefit many areas in healthcare, including the diagnosis of skin cancer using teledermatoscopy. However, there is a dearth of clinical, prospective research o...
Eligibility Criteria
Inclusion
- Licensed physician
- Working at a dermatology clinic
- Sufficient knowledge in Swedish
- Written consent to participate
Exclusion
- No experience of using dermatoscopy
- Does not wish to participate
- Incomplete answers
- Physicians that are involved in the patients' clinical care relating to the teledermoscopical consult
Key Trial Info
Start Date :
February 15 2023
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
October 30 2024
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT06080711
Start Date
February 15 2023
End Date
October 30 2024
Last Update
October 12 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Karolinska University Hospital
Stockholm, Sweden